Aims: Bioresorbable vascular scaffolds (BVS) represent a novel therapeutic option for the treatment of coronary artery diseases. The objective of this study was to evaluate the feasibilit
Jiang Ming Fam1, MD; Soledad Ojeda2, MD, PhD; Roberto Garbo3, MD; Azeem Latib4, MD; Alessio La Manna5, MD; Beatriz Vaquerizo6, MD; Marouane Boukhris7, MD; Georgios J. Vlachojannis8, MD, PhD; Robert-Jan van Geuns1, MD, PhD; Babu Ezhumalai9, MD; Hiroyoshi Kawamoto4, MD; Jors van der Sijde1, MD; Cordula Felix1, MD; Manuel Pan2, MD, PhD; Roberta Serdoz10, MD; Giacomo Giovanni Boccuzzi3, MD; Marcella De Paolis1, MD; Gennaro Sardella11, MD; Massimo Mancone
1. Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands; 2. Department of Cardiology, Reina Sofia Hospital, University of Córdoba (IMIBIC), Córdoba, Spain; 3. Department of Cardiology, San Giovanni Bosco Hospital,
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
bioresorbable scaffoldschronic coronary total occlusionstable angina
Coronary interventionsStents and scaffoldsCTO